L.M. Kohn & Company Decreases Stock Position in BlackRock Health Sciences Trust $BME

L.M. Kohn & Company cut its position in BlackRock Health Sciences Trust (NYSE:BME) by 10.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,948 shares of the company’s stock after selling 704 shares during the quarter. L.M. Kohn & Company’s holdings in BlackRock Health Sciences Trust were worth $217,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in BME. Cambridge Investment Research Advisors Inc. boosted its stake in shares of BlackRock Health Sciences Trust by 14.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 50,654 shares of the company’s stock valued at $1,957,000 after purchasing an additional 6,257 shares during the period. Oppenheimer & Co. Inc. boosted its stake in shares of BlackRock Health Sciences Trust by 8.4% in the first quarter. Oppenheimer & Co. Inc. now owns 6,295 shares of the company’s stock valued at $243,000 after purchasing an additional 486 shares during the period. Calamos Advisors LLC purchased a new position in shares of BlackRock Health Sciences Trust in the first quarter valued at $251,000. Stratos Wealth Partners LTD. boosted its stake in shares of BlackRock Health Sciences Trust by 7.9% in the first quarter. Stratos Wealth Partners LTD. now owns 7,037 shares of the company’s stock valued at $272,000 after purchasing an additional 517 shares during the period. Finally, Fountainhead AM LLC purchased a new position in shares of BlackRock Health Sciences Trust in the first quarter valued at $204,000.

BlackRock Health Sciences Trust Stock Performance

Shares of BME stock opened at $38.04 on Thursday. The firm has a fifty day simple moving average of $37.20 and a 200-day simple moving average of $36.52. BlackRock Health Sciences Trust has a twelve month low of $34.18 and a twelve month high of $41.36.

BlackRock Health Sciences Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, October 31st. Shareholders of record on Wednesday, October 15th will be issued a dividend of $0.2621 per share. This represents a c) annualized dividend and a yield of 8.3%. The ex-dividend date of this dividend is Wednesday, October 15th.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.